Universe Pharmaceuticals INC
UPC
$4.20
$0.4010.53%
NASDAQ
03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 0.00% | -38.45% | 0.00% | -29.56% | 0.00% |
Total Receivables | 0.00% | 34.06% | 0.00% | -38.76% | 0.00% |
Inventory | 0.00% | 1.28% | 0.00% | 8.69% | 0.00% |
Prepaid Expenses | 0.00% | -1.26% | 0.00% | 101.60% | 0.00% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 0.00% | 104.32% | 0.00% | -95.04% | 0.00% |
Total Current Assets | 0.00% | -8.91% | 0.00% | -29.91% | 0.00% |
|
|||||
Total Current Assets | 0.00% | -8.91% | 0.00% | -29.91% | 0.00% |
Net Property, Plant & Equipment | 0.00% | -4.78% | 0.00% | -10.72% | 0.00% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 0.00% | -0.61% | 0.00% | -7.41% | 0.00% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | -3.39% | 0.00% | -6.84% | 0.00% |
Total Assets | 0.00% | -7.24% | 0.00% | -24.27% | 0.00% |
|
|||||
Total Accounts Payable | 0.00% | 69.32% | 0.00% | -59.20% | 0.00% |
Total Accrued Expenses | 0.00% | -7.88% | 0.00% | 45.84% | 0.00% |
Short-term Debt | 0.00% | -19.16% | 0.00% | 34.47% | 0.00% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 0.00% | 921.14% | 0.00% | -90.64% | 0.00% |
Total Other Current Liabilities | 0.00% | 921.14% | 0.00% | -90.64% | 0.00% |
Total Current Liabilities | 0.00% | 49.84% | 0.00% | -40.82% | 0.00% |
|
|||||
Total Current Liabilities | 0.00% | 49.84% | 0.00% | -40.82% | 0.00% |
Long-Term Debt | 0.00% | -- | -- | -- | -- |
Short-term Debt | 0.00% | -19.16% | 0.00% | 34.47% | 0.00% |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 0.00% | 64.94% | 0.00% | -40.82% | 0.00% |
|
|||||
Common Stock & APIC | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Retained Earnings | 0.00% | -103.99% | 0.00% | -30.19% | 0.00% |
Treasury Stock & Other | 0.00% | 12.97% | 0.00% | -804.20% | 0.00% |
Total Common Equity | 0.00% | -32.35% | 0.00% | -16.11% | 0.00% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 0.00% | -32.35% | 0.00% | -16.11% | 0.00% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 0.00% | -32.35% | 0.00% | -16.11% | 0.00% |
|